Company News

Share this article:

Sen. Chuck Grassley (R-IA) has written to Pfizer requesting details about payments the company made to 149 Harvard Medical School faculty members and doctors. A Pfizer spokesperson told the New York Times that the company “will fully cooperate with Senator Grassley's request for information.”

 

Vertex Pharmaceuticals has acquired Canadian drugmaker ViroChem Pharma for $100 million in cash, and 9.9 million shares of Vertex common stock. The acquisition adds two early-stage hepatitis C drugs to the company's portfolio, VCH-222 and VCH-759.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.

Insurers get personal to nip costs

Healthcare insurers seek to curb diabetes costs with interventions that may include house calls.

Novartis dials down RNA research

The drugmaker says the therapeutic approach has a narrow treatment potential.